Literature DB >> 16750894

Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease.

C Ayala-Grosso1, J Tam2, S Roy2, S Xanthoudakis2, D Da Costa1, D W Nicholson2, G S Robertson3.   

Abstract

Corticocortical disconnection in Alzheimer's disease occurs by the progressive impairment and eventual loss of a small subset of pyramidal neurons in layers III and V of association areas of the neocortex. These neurons exhibit large somatic size, extensive dendritic arborization and high levels of nonphosphorylated neurofilaments of medium and high molecular weight that can be identified using a monoclonal SMI-32 antibody. It is thought that the accumulation of amyloid Abeta and neurofibrillary tangles may provoke metabolic disturbances that result in the loss of these SMI-32 immunoreactive neurons. The recent detection of increased levels of caspase-3 cleaved fodrin in frontal, temporal and parietal association areas in Alzheimer's disease brains suggests that programmed cell death may contribute to the destruction of SMI-32 positive neurons. In the present study, we utilized an antibody that selectively recognizes the 120 kDa breakdown product of alphaIIspectrin (fodrin) generated by caspase-3 to determine whether this protease is activated in vulnerable pyramidal neurons located in layers III and V of Alzheimer's disease brains. Neurons immunoreactive for caspase-3 cleaved alphaIIspectrin were located predominantly in layers III and V of the inferior frontal and superior temporal cortices of patients with Alzheimer's disease but not age-matched controls. Pyramidal neurons immunoreactive for caspase-3 cleaved alphaIIspectrin invariably displayed SMI-32 immunoreactivity suggesting that caspase-3 activation is a pathological event that may be responsible for the loss of a subset of pyramidal neurons that comprise corticocortical projections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750894     DOI: 10.1016/j.neuroscience.2006.04.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

Review 1.  Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology.

Authors:  Bradley T Hyman; Junying Yuan
Journal:  Nat Rev Neurosci       Date:  2012-05-18       Impact factor: 34.870

2.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

3.  Increased immunoreactivities of cleaved αII-spectrin and cleaved caspase-3 in the aged dog spinal cord.

Authors:  In Koo Hwang; Ji Hyeon Ahn; Dae Young Yoo; Choong Hyun Lee; Ki-Yeon Yoo; Jung Hoon Choi; Seung Myung Moon; Hyung-Cheul Shin; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

4.  Self-assembled polymersomes conjugated with lactoferrin as novel drug carrier for brain delivery.

Authors:  Yuan Yu; Zhiqing Pang; Wei Lu; Qi Yin; Huile Gao; Xinguo Jiang
Journal:  Pharm Res       Date:  2011-10-07       Impact factor: 4.200

5.  Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease.

Authors:  Natalia Louneva; Julia W Cohen; Li-Ying Han; Konrad Talbot; Robert S Wilson; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 6.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

7.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

Review 8.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

9.  Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.

Authors:  Mala V Rao; Panaiyur S Mohan; Corrinne M Peterhoff; Dun-Sheng Yang; Stephen D Schmidt; Philip H Stavrides; Jabbar Campbell; Yuanxin Chen; Ying Jiang; Peter A Paskevich; Anne M Cataldo; Vahram Haroutunian; Ralph A Nixon
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.

Authors:  R Thangavel; S K Sahu; G W Van Hoesen; A Zaheer
Journal:  Neuroscience       Date:  2009-02-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.